Structure-and-Mechanism-Based Design and Discovery of Type II Mycobacterium Tuberculosis Dehydroquinate Dehydratase Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|14|1|51-63

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.14, Iss.1, 2014-01, pp. : 51-63

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Computational Sampling and Simulation Based Assessment of Novel Mycobacterium tuberculosis Glutamine Synthetase Inhibitors: Study Involving Structure Based Drug Design and Free Energy Perturbation

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 9, 2016-04 ,pp. : 978-995

Bentham Science Publishers

Access to resources Recommend Favorite

Design and In Vitro Evaluation of Five Inhibitors of Mycobacterium Tuberculosis

By  

Letters in Drug Design & Discovery, Vol. 4, Iss. 2, 2007-03 ,pp. : 137-143

Bentham Science Publishers

Access to resources Recommend Favorite

Type II NADH:Menaquinone Oxidoreductase of Mycobacterium tuberculosis

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 7, Iss. 2, 2007-06 ,pp. : 169-181

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of Shikimate Kinase and Type II Dehydroquinase for Antibiotic Discovery: Structure-Based Design and Simulation Studies

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 9, 2016-04 ,pp. : 960-977

Bentham Science Publishers

Access to resources Recommend Favorite

Bissulfonamides as inhibitors of the dehydroquinate synthetase enzyme AroB and of the Type II dehydroquinase enzyme AroQ

By  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 11, 2001-11 ,pp. : 1797-1799

Informa Healthcare

Access to resources Recommend Favorite